B-ENT
Review

Consensus Statement on the Treatment with Implantable Bone Conducting Hearing Devices in Belgium

1.

Cochlear Benelux nv, Mechelen, Belgium

2.

Department of Otorhinolaryngology, Head and Neck Surgery, Antwerp University Hospital, Antwerp, Belgium

3.

Department of Otorhinolaryngology, Head and Neck Surgery, Cliniques universitaires Saint-Luc, Brussels, Belgium

4.

Audio-Phonological Center, Université Catholique de Louvain, Brussels, Belgium

5.

MUCLA, University Hospitals Leuven, Leuven, Belgium

6.

Amplifon, University Hospital Ghent, Ghent, Belgium

7.

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Ghent, Ghent, Belgium

8.

Department of Otorhinolaryngology and Logopaedic-Audiologic Sciences, Ghent University Faculty of Medicine and Health Sciences, Ghent, Belgium

9.

Department of Otorhinolaryngology, Tivoli University Hospital, La Louvière, Belgium

10.

Greenham Research Consulting Ltd., Ashbury, UK

11.

Department of Otorhinolaryngology & Head and Neck Surgery, Jessa Hospital, Hasselt, Belgium

12.

Department of Otorhinolaryngology, Head and Neck Surgery, AZ Sint Jan Brugge-Oostende AV, Bruges, Belgium

13.

Department of Otorhinolaryngology, Ziekenhuis Oost Limburg, Genk, Belgium

14.

Deparment of Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, Belgium

15.

Department of Otorhinolaryngology & Head and Neck Surgery, Antwerp University Hospital, Belgium

16.

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospitals Leuven, Leuven, Belgium

17.

Department of Neurosciences, KU Leuven, University of Leuven, ExpORL, Leuven, Belgium

B-ENT 2023; 19: 127-133
DOI: 10.5152/B-ENT.2023.21692
Read: 1094 Downloads: 561 Published: 01 April 2023

To provide guiding principles to deliver high-quality treatment with implantable bone conducting hearing devices and to guarantee the best possible outcomes for each patient in Belgium. A consensus meeting was convened on March 26, 2019, including surgeons and audiologists from different bone conducting hearing devices hospitals and fitting centers in Belgium, and an independent moderator. First, different care models for treatment with bone conducting hearing devices, currently applied in Belgium, were identified and discussed. It was agreed that bone conducting hearing devices surgery and fitting should be provided by clinicians with adequate training and experience and that bone conducting hearing devices care should be centralized as much as possible. Preferably sound processor fitting is carried out within the bone conducting hearing devices hospital or at a specialized fitting center outside the hospital. In any case, a close interdisciplinary collaboration between both the bone conducting hearing devices surgeon and the bone conducting hearing devices audiologist was considered critical to ensure good patient outcomes (e.g., to facilitate appropriate treatment in the event of complications). Second, general guidelines were debated and agreed upon to improve the quality of care for the different phases of the patient journey (referral, assessment, treatment, and follow-up). Providing a standard of care means that every person, regardless of the type or degree of hearing loss, the region in which they reside and the healthcare professional they see, has access to a standardized assessment and treatment process, resulting in the most efficient hearing solution for his or her indication. This consensus statement was a first step towards a more standardized approach for treatments with bone conducting hearing devices in Belgium.

Cite this article as: Claes AJ, Bouzegta R, Deggouj N, et al. Consensus statement on the treatment with implantable bone conducting hearing devices in belgium. B-ENT. 2023;19(2):127-133.

Files
EISSN 2684-4907